SCHEMBL25760164

SCHEMBL25760164

CCc1cccc(Cc2nc3c(Cc4ccccc4)[nH]c(-c4cccc(O)c4)cn-3c2=O)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 1/20 0.37
▸ ADORA2A P29274 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ CASR P41180 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ PDE3B Q13370 1/20 0.34
▸ PDE3A Q14432 1/20 0.34
▸ CCNB2 O95067 1/20 0.34
▸ CCNE2 O96020 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ CDK4 P11802 1/20 0.34
▸ CCNB1 P14635 1/20 0.34
▸ CCND1 P24385 1/20 0.34
▸ CCNE1 P24864 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CCNB3 Q8WWL7 1/20 0.34
▸ KIF11 P52732 4/20 0.34
▸ PARP1 P09874 2/20 0.34
▸ CSF1R P07333 1/20 0.34
▸ ALOX5 P09917 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21751336 0.94 ADORA3 (0.41) ADORA3ADORA2AADORA1CASRALDH1A1
SCHEMBL25760179 0.92 CASR (0.39) ADORA3ADORA2AADORA1CASRALDH1A1
SCHEMBL30800148 0.91 ADORA3 (0.39) ADORA3ADORA2AADORA1CASRALDH1A1
SCHEMBL21751454 0.91 ADORA3 (0.39) ADORA3ADORA2AADORA1CASRALDH1A1
SCHEMBL19206714 0.91 ALDH1A1 (0.38) ADORA3ADORA2AADORA1CASRALDH1A1
SCHEMBL21751340 0.91 ADORA3 (0.36) ADORA3ADORA2AADORA1CASRALDH1A1
SCHEMBL25760174 0.91 CASR (0.38) ADORA3ADORA2AADORA1CASRALDH1A1
SCHEMBL25760166 0.90 THRB (0.38) ALDH1A1PDE3BPDE3ACCNE2CCNE1
SCHEMBL21751401 0.89 LTB4R (0.43) ALDH1A1ALOX5
SCHEMBL21751359 0.89 ADORA3 (0.37) ADORA3ADORA2AADORA1CASRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691976-B2 Coelenterazine analogues PROMEGA CORPORATION (US) 2023-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691976-B2 Coelenterazine analogues GLB1, SI, TCF7L2 ADORA3 3089/4885ADORA2A 1970/4885ADORA1 4310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback